Abstract
HIV-1 latency in resting CD4 + T cells represents a major barrier to virus eradication in patients on highly active antiretroviral therapy (HAART). Eliminating the latent HIV-1 reservoir may require the reactivation of viral gene expression in latently infected cells. Most approaches for reactivating latent HIV-1 require nonspecific T cell activation, which has potential toxicity. To identify factors for reactivating latent HIV-1 without inducing global T cell activation, we performed a previously undescribed unbiased screen for genes that could activate transcription from the HIV-1 LTR in an NF-κB-independent manner, and isolated an alternatively spliced form of the transcription factor Ets-1, δVII-Ets-1. δVII-Ets-1 activated HIV-1 transcription through 2 conserved regions in the LTR, and reactivated latent HIV-1 in cells from patients on HAART without causing significant T cell activation. Our results highlight the therapeutic potential of cellular factors for the reactivation of latent HIV-1 and provide an efficient approach for their identification.
Original language | English (US) |
---|---|
Pages (from-to) | 6321-6326 |
Number of pages | 6 |
Journal | Proceedings of the National Academy of Sciences of the United States of America |
Volume | 106 |
Issue number | 15 |
DOIs | |
State | Published - Apr 14 2009 |
Keywords
- Antiretroviral therapy
- Expression cloning
- Long terminal repeat
- Viral reservoir
- δVII-Ets-1
ASJC Scopus subject areas
- General